SCHEMBL1668058

SCHEMBL1668058

Cn1nc(C(F)(F)F)c2cc(C(N)=O)sc21

nearest known ligand 0.71

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.71
PKM P14618 1/20 0.71
L3MBTL1 Q9Y468 2/20 0.70
PIM3 Q86V86 1/20 0.65
PIM2 Q9P1W9 1/20 0.65
ALDH1A1 P00352 7/20 0.64
CYP1A2 P05177 2/20 0.64
CYP2C19 P33261 1/20 0.64
GAA P10253 2/20 0.62
MAPT P10636 7/20 0.61
MEN1 O00255 4/20 0.61
KMT2A Q03164 4/20 0.61
NPSR1 Q6W5P4 1/20 0.61
KDM4E B2RXH2 3/20 0.58
MAPK1 P28482 1/20 0.56
LMNA P02545 3/20 0.49
HPGD P15428 2/20 0.49
APOBEC3G Q9HC16 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5924831 0.88 NPC1 (0.80) NPC1PKML3MBTL1PIM3PIM2
SCHEMBL23080979 0.81 KDM4E (0.54) NPC1PKML3MBTL1PIM3PIM2
SCHEMBL23657726 0.76 MAPT (0.83) NPC1PKML3MBTL1ALDH1A1CYP1A2
SCHEMBL1520260 0.74 MAPT (0.60) NPC1PKML3MBTL1ALDH1A1CYP1A2
SCHEMBL12000239 0.72 MAPT (0.61) NPC1PKML3MBTL1ALDH1A1CYP1A2
SCHEMBL13137673 0.71 MAPT (0.60) NPC1PKML3MBTL1ALDH1A1CYP1A2
SCHEMBL1520694 0.68 PIM3 (0.74) NPC1PKML3MBTL1PIM3PIM2
SCHEMBL21563866 0.65 MAPT (0.53) NPC1PKML3MBTL1ALDH1A1CYP1A2
SCHEMBL20239461 0.65 PIM3 (0.74) NPC1PKML3MBTL1PIM3PIM2
SCHEMBL762871 0.65 NPC1 (0.52) NPC1PKML3MBTL1PIM3PIM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2509974-A1 PYRAZOLES DERIVATIVES MODULATORS OF CALCIUM RELEASE -ACTIVATED CALCIUM CHANNEL AND METHODS FOR TREATMENT OF NON- SMALL CELL LUNG CANCER Rhizen Pharmaceuticals S.A. (CH) 2012-10-17 EP claimed
WO-2011042798-A1 PYRAZOLES DERIVATIVES MODULATORS OF CALCIUM RELEASE -ACTIVATED CALCIUM CHANNEL AND METHODS FOR TREATMENT OF NON- SMALL CELL LUNG CANCER INCOZEN THERAPEUTICS PVT. LTD. (IN) 2011-04-14 WO claimed